Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy care continuum communication

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Feds threaten Sanofi with sanctions over plan to change payment terms for a federal drug discount program - 10 days ago STAT+: Pharmacies sue GoodRx and PBMs over ‘illegal’ reimbursement fees - about 2 months ago STAT+: Two generic drugmakers to pay $49 million to settle price-fixing charges - about 2 months ago STAT+: Sales from controversial drug discount program rose to $63 billion last year - 2 months ago STAT+: Pharmalittle: We’re reading about FTC scrutiny of a Novo deal, a Genentech reorganization, and more - 4 months ago STAT+: Pharmalittle: We’re reading about AbbVie spending on doctors, a new Lilly deal, and more - 6 months ago STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more - 9 months ago STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more - 10 months ago STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more - 10 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 10 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - 10 months ago STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more - 11 months ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - 12 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - about 1 year ago STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds - about 1 year ago STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast - about 1 year ago STAT+: Pharmalittle: CVS to overhaul how it’s paid for drugs; Biden drug-shortage plan won’t expand chemo supplies - about 1 year ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - about 1 year ago STAT+: Health plan formularies lowered barriers to fair access to some drugs, analysis finds - about 1 year ago STAT+: Medicare is urged to consider Amgen patent maneuvers when negotiating the price for a drug - about 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - about 1 year ago STAT+: Pharmalittle: Pfizer prices Paxlovid at $1,400 for a five-day course; EMA warns of counterfeit Ozempic - about 1 year ago STAT+: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs - about 1 year ago STAT+: Pharmalittle: U.S. Chamber and feds clash on Medicare price negotiation; South Africa probes J&J over TB-drug pricing - over 1 year ago
2	Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. Healthcarejournalism	Experts Weigh Benefits of Drug Price Negotiation and Other Price-Curbing Strategies - 11 days ago Drug Prices Negotiated by Medicare Still Higher Than Other Countries' - 21 days ago What's Happening With the Medicare Drug-Price Negotiation Lawsuits? - 9 months ago Medical Schools Push Back on 'March-In' Rights Plan to Lower Drug Prices - 11 months ago Experts, Lawmakers Explore Downside of Drug-Price Negotiation - about 1 year ago White House Says It Can Seize Certain Drug Patents to Lower Prices - about 1 year ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Trump’s tariffs could put more pressure on the U.S. to produce generic drugs. Are we ready? - 18 days ago Is anyone taking the world’s priciest drugs? - 4 months ago
4	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Novo Nordisk sells hit weight-loss drug in China—at fraction of US price - about 1 month ago Medicare drug price negotiations: 10 list prices drop between 38% to 79% - 4 months ago Big Pharma’s fight against drug price reforms takes weird, desperate turn - 6 months ago Big Pharma fought drug pricing reform with record $7.5M dark money donation - about 1 year ago
5	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Higher insurance costs eat into savings from drug pricing law by more than expected - 3 months ago STAT+: Venture capital is still pouring into drug research despite Medicare price negotiation - about 1 year ago STAT+: Hearing on Medicare drug price negotiation gets unusually heated - over 1 year ago
6	Rebecca Pifer Healthcare Dive Reporter @healthcaredive. New York City, United States insurancedigital health	Large employers forecast 7.8% hike in health costs next year, thanks to rising pharmacy spend - 4 months ago CVS overhauls how its retail pharmacies charge for prescription drugs - about 1 year ago Optum Rx moves 8 insulins to preferred formulary status as pressure mounts on PBMs - about 1 year ago
7	Joyce Frieden MedPage Today Washington editor at MedPage Today. Board member at AHCJ. Greater Washington, DC area Healthcare journalism	Is Medicare's Negotiated Drug Price List Worth Celebrating? Depends on Whom You Ask. - 4 months ago Biden Administration Announces Moves to Cut Drug Prices - about 1 year ago States Making Progress Toward Setting Payment Limits for Some Drugs - about 1 year ago
8	Jonathan Gardner Healthcare Dive Senior reporter. BioPharma Dive. Charlottesville, Virginia BiopharmaceuticalsJournalism	Medicare drug price cuts could have limited early impact, but grow with time - 4 months ago
9	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	The drugs hit hardest by Medicare price negotiations - 4 months ago Pharma execs react to final drug price negotiations with Medicare - 5 months ago 3 Big Pharma cancer drugs facing inflation penalties - 5 months ago The IRA will lower U.S. drug spending, CMS finds — but not for awhile - 6 months ago Cutting pills. Rationing insulin. How Americans struggle to pay for drugs. - 9 months ago Could pharma’s legal attack on the IRA succeed in killing price negotiations? - 10 months ago
10	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	CMS Touts First Negotiated Drug Prices, But Greater Impact Expected in Future Rounds - 4 months ago

Journalists covering Drug prices